Genmab | Pasivo Circulante



Current Liabilities Cambio Fecha
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Almirall EUR 298.52M 36.18M 2025-06
Amarin USD 162.41M 17.54M 2025-03
Amgen USD 20.48B 2.53B 2025-06
argenx SE 1.04B 371.99M 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Bayer EUR 29.78B 1.82B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Demant DKK 5.79B 301M 2025-06
Exelixis USD 336.11M 62.99M 2025-07
Fresenius Medical Care EUR 5.66B 213.7M 2025-06
Galapagos EUR 402.95M 34.09M 2025-06
Genmab DKK 629M 127M 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
GN Store Nord DKK 7.89B 5.69B 2025-03
GRIFOLS EUR 1.99B 180.07M 2025-06
Hikma Pharmaceutical USD 1.98B 598M 2024-12
Insmed USD 311.68M 72.45M 2025-06
Lonza CHF 3.58B 970M 2024-12
Merck EUR 9.86B 357M 2025-06
Novartis USD 31.71B 95M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.06B 3.16B 2025-06
UCB EUR 3.53B 731M 2024-12


Genmab Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.